Brentuximab vedotin : approved_treatment(s) : Hodgkin lymphoma , Anaplastic large-cell lymphoma | Brentuximab vedotin : target : CD30
All the approved treatments for the target CD30 are hodgkin lymphoma, anaplastic large - cell lymphoma.